See All News - tctmd.com

News

News Industry News

Terumo Cardiovascular Group and Talis Clinical Introduce ACG-Perfusion™ and ACG-RemoteView™ Systems, Enhancing Efficiency of Clinical Care Team

May 07, 2019

News Daily News

PFO Compounds Ischemic Stroke Risk Among Patients With Pulmonary Embolism

Yael L. Maxwell

May 06, 2019

News Daily News

Vici Venous Stent Receives FDA Approval for Iliofemoral Obstructive Disease

L.A. McKeown

May 06, 2019

News Daily News

Elevations in hs-cTnI Linked to Higher Risk of CVD, Particularly Heart Failure

Michael O'Riordan

May 06, 2019

News Daily News

Tafamidis Approved for Treatment of Transthyretin Amyloid Cardiomyopathy

Michael O'Riordan

May 06, 2019

News Industry News

Neovasc Announces Treatment of 1,000th Refractory Angina Patient with Neovasc Reducer™

May 06, 2019

News Industry News

Abbott Launches Next-Generation Detection Technology In The U.S. And Europe, Offering A Smarter Approach To 24/7 Heart Monitoring For People With Irregular Heartbeats

May 06, 2019

News Industry News

Boston Scientific Receives U.S. FDA Approval for The VICI VENOUS STENT™ System

May 06, 2019

News Industry News

FDA approves new treatments for heart disease caused by a serious rare disease, transthyretin mediated amyloidosis

May 06, 2019

News Daily News

Low-Level Ionizing Radiation May Raise Hypertension Risk

L.A. McKeown

May 03, 2019

Advertisement

News

Terumo Cardiovascular Group and Talis Clinical Introduce ACG-Perfusion™ and ACG-RemoteView™ Systems, Enhancing Efficiency of Clinical Care Team

PFO Compounds Ischemic Stroke Risk Among Patients With Pulmonary Embolism

Vici Venous Stent Receives FDA Approval for Iliofemoral Obstructive Disease

Elevations in hs-cTnI Linked to Higher Risk of CVD, Particularly Heart Failure

Tafamidis Approved for Treatment of Transthyretin Amyloid Cardiomyopathy

Neovasc Announces Treatment of 1,000th Refractory Angina Patient with Neovasc Reducer™

Abbott Launches Next-Generation Detection Technology In The U.S. And Europe, Offering A Smarter Approach To 24/7 Heart Monitoring For People With Irregular Heartbeats

Boston Scientific Receives U.S. FDA Approval for The VICI VENOUS STENT™ System

FDA approves new treatments for heart disease caused by a serious rare disease, transthyretin mediated amyloidosis

Low-Level Ionizing Radiation May Raise Hypertension Risk

Search News

Advertisement

Advertisement

News

Search News

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content